Adam Zlotnick is one of the three faculty members recently appointed as Distinguished Professors, the most prestigious appointment offered to honor faculty whose outstanding scholarship, artistic or literary distinction or other achievements have won significant recognition by peers.
As a member of the IU community since 2008, professor Adam Zlotnick takes scientific discovery from the bench to the bedside in a manner that has important and positive human health benefits. His research has advanced several novel antiviral drug candidates, one of which advanced to Phase Two clinical trials and proved to be highly effective and safe in the treatment of hepatitis B.
He has over 140 publications that have generated over 12,000 citations and 12 patents, 11 of which were filed while at IU, underpinning his international reputation and his ability to obtain significant public funding, including from the National Institutes of Health, and private funding for his research efforts. His research and leadership have led to the launch of two biotech companies, one of which is now a public company recognized as the leader in hepatitis B virus therapeutics.
Zlotnick is the fourth MCB faculty member to be honored. The other three are Craig Pikaard, Carl Bauer, and Steve Bell.
Congratulations Distinguished Professor Adam Zlotnick!
The College of Arts